99mTc-radiolabeled TROP2 targeting nanobody (Shanghai Novamab Biopharmaceuticals/Chinese Academy of Sciences/Peking Union Medical College Hospital/Peking University)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Name99mTc-radiolabeled TROP2 targeting nanobody (Shanghai Novamab Biopharmaceuticals/Chinese Academy of Sciences/Peking Union Medical College Hospital/Peking University)
Drug Alias Name99mTc-Trop2-VHHtechnetium-99m-TROP2-VHHVHH-TROP2-[technetium-99m]
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agent
Mechanisms of ActionTumor-associated calcium signal transducer 2 modulators
TargetsTumor-associated calcium signal transducer 2
Therapy Area/IndicationsTriple Negative Breast NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesPeking University
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Chinese Academy of SciencesPeking Union Medical College HospitalPeking University +[4] 
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A